Clinical Trials in Cleveland

Showing 1241-1260 of 19,775 trials

Ruxolitinib for the Treatment of Chronic Myelomonocytic Leukemia (CMML): A Phase 2 Expansion

NCT03722407

This study is to find out if treating Chronic Myelomonocytic Leukemia (CMML) with a study drug (ruxolitinib) can improve outcomes of patients with CMML.

Chronic Myelomonocytic LeukemiaLeukemia

H. Lee Moffitt Cancer Center and Research Institute29 participantsStarted Aug 2019

Tampa, Florida, United States • Baltimore, Maryland, United States • Boston, Massachusetts, United States +2 more locations

RECRUITINGNA< 1 mile

S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer

NCT03723928

This randomized research trial studies how well serum tumor marker directed disease monitoring works in monitoring patients with hormone receptor positive Her2 negative breast cancer that has spread to other places in the body. Using markers to prompt when scans should be ordered may be as good as the usual approach to monitoring disease.

Anatomic Stage IV Breast Cancer AJCC v8Estrogen Receptor PositiveHER2/Neu Negative+3 more

SWOG Cancer Research Network739 participantsStarted Sep 2018

Anchorage, Alaska, United States • Anchorage, Alaska, United States • Anchorage, Alaska, United States +720 more locations

Ruxolitinib for the Treatment of Chronic Myelomonocytic Leukemia (CMML): A Phase 2 Expansion

S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer

Find Trials by Condition in Cleveland

Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC)

Flourish in Schools Pilot Study

ADAPT - A Patient Registry of the Real-world Use of Orenitram®

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

A Study of KarXT + KarX-EC for Treatment of Irritability in Children and Adolescents With Autism Spectrum Disorder

Post Market Evaluation of Clinical Safety and Performance of the Fitbone Transport and Lengthening System

A Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anatomic Stage I Hormone Receptor-positive, HER2-positive Breast Cancer

Biomarker and Edema Attenuation in IntraCerebral Hemorrhage (BEACH)

Prophylactic DR-CPAP on Late Preterm Infants Born by C-section: an RCT

Phase 2b Safety and Efficacy Study of CGB-500 Topical Ointment With 0.5% and 1% Tofacitnib for Treatment of Atopic Dermatitis

Study to Evaluate Efficacy & Safety of Afuresertib Plus Fulvestrant in Patients With Locally Advanced or Metastatic HR+/HER2- Breast Cancer

BrUOG 354 Nivolumab +/- Ipilimumab for Ovarian and Extra-renal Clear Cell Carcinomas

The Purpose of This Study is to Evaluate the Safety and Efficacy of D-MNA in Adult Patients With Nodular Basal Cell Carcinoma

Linaclotide in Treating Patients With Stages 0-3 Colorectal Cancer

Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast Cancer

This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors

A Phase I/II GVHD Prevention Trial Combining Pacritinib With Sirolimus-Based Immune Suppression